Category: Alzheimer’s Disease

June 24, 2019

Blog: Exploring the Real-World Medicare Costs of Alzheimer’s Disease with Bruce Pyenson

Bruce Pyenson, principal and consulting actuary at Milliman The July issue of the Journal of Managed Care and Specialty Pharmacy…
May 14, 2019

Blog: How a Woman with Alzheimer’s Disease Lives Every Second

Terrie Montgomery was diagnosed with early onset Alzheimer’s disease in 2015. Since being diagnosed with early onset Alzheimer’s disease, Terrie…
March 20, 2019

Alliance for Aging Research Releases Survey Results Highlighting Public Interest in Detecting Alzheimer’s Disease Early and Participating in Clinical Trials

New Survey Finds That Although Understanding of Alzheimer’s Disease is Limited to Personal Experience, Respondents Were Interested in…
March 13, 2019

Alliance for Aging Research Statement on FY 2020 White House Proposed Budget

Alliance for Aging Research President and CEO Susan Peschin, MHS, issued the following statement in response to the White House’s…
January 28, 2019

Chairman’s Blog: Trends in Aging

James “Jim” G. Scott, Chair, Alliance for Aging Research Board of Directors. Health care in 2019 will no doubt be…
October 31, 2018

Alzheimer’s Disease (ACT-AD) Coalition Goes to Barcelona

In October, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition, which is chaired by the Alliance for Aging Research, attended the …
June 15, 2018

ACT-AD Coalition Letter on FDA Early Alzheimer’s Disease Guidance

The majority of clinical trials conducted in Alzheimer’s disease have been for patients who received a definitive diagnosis after becoming…
June 8, 2018

The Chairman’s Blog: Medicare Should Help Patients Avoid the Angst of an Incorrect Alzheimer’s Diagnosis

Every year, thousands of Americans hear the devastating news that they have Alzheimer’s disease.  This diagnosis carries with it a…
December 1, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Last month, the Clinical Trials for Alzheimer's Disease (CTAD) conference was held in Boston. Phyllis Greenberger, Senior Vice President of Science & Health Policy, HealthyWomen, shares her experiences at the conference.
November 7, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Last week was the Clinical Trials for Alzheimer’s Disease (CTAD) conference in Boston. The Alliance's Missy Jenkins and Ryne Carney were in attendance, as were those from various other organizations. We are pleased to present a post from Eric Sokol, vice president, Public Policy, the Alzheimer’s Foundation, about some of the highlights from the conference.